A 38-year-old woman presents to the emergency department with severe palpitations, tremor, and anxiety. Her blood pressure is 165/95 mmHg and heart rate is 118 bpm. On examination, she appears diaphoretic. Serum glucose is 285 mg/dL, and plasma catecholamines are markedly elevated. A diagnosis of pheochromocytoma is suspected. Which of the following best explains the cellular mechanism by which catecholamines produce these cardiovascular and metabolic effects?

Question

Accepted Answer

B. Activation of β1-adrenergic receptors leading to increased cAMP, which activates protein kinase A and increases cardiac contractility and heart rate. ## Mechanism of Catecholamine Action in Pheochromocytoma

### Second Messenger Pathway in β1-Adrenergic Signaling

Catecholamines (epinephrine and norepinephrine) released from pheochromocytoma bind to **β1-adrenergic receptors** on cardiac myocytes and vascular smooth muscle. This activates a G-protein coupled receptor pathway:

1. β1-receptor activation → G~s~ protein coupling
2. Activation of **adenylyl cyclase**
3. Increased production of **cAMP** (the second messenger)
4. cAMP activates **protein kinase A (PKA)**
5. PKA phosphorylates:
   - L-type calcium channels → increased Ca²⁺ influx
   - Troponin I and myosin light chain kinase → increased contractility
   - Phospholamban → enhanced sarcoplasmic reticulum Ca²⁺ release

### Clinical Manifestations

**Key Point:** The cAMP-PKA cascade explains all the acute symptoms in this patient:
- **Increased heart rate** (positive chronotropic effect)
- **Increased contractility** (positive inotropic effect)
- **Elevated blood pressure** (combined with α1-mediated vasoconstriction)
- **Hyperglycemia** (PKA phosphorylates glycogen phosphorylase and inhibits glycogen synthase)
- **Tremor** (β2-mediated effects on skeletal muscle)

### Comparison of Adrenergic Receptor Pathways

| Receptor | G-protein | Second Messenger | Effect |
|----------|-----------|------------------|--------|
| **β1** | G~s~ | **cAMP ↑** | ↑ HR, ↑ contractility, ↑ metabolism |
| **β2** | G~s~ | **cAMP ↑** | Vasodilation, bronchodilation, tremor |
| **α1** | G~q~ | **IP3/DAG ↑** | Vasoconstriction, ↑ contractility |
| **α2** | G~i~ | **cAMP ↓** | Inhibitory, ↓ NE release |

**High-Yield:** In pheochromocytoma, the **β1-cAMP-PKA axis** is responsible for the cardiac and metabolic manifestations (tachycardia, hyperglycemia, tremor), while **α1-IP3/DAG signaling** contributes to hypertension and vasoconstriction.

**Clinical Pearl:** The combination of severe hypertension + tachycardia + hyperglycemia + tremor is pathognomonic for catecholamine excess and should immediately raise suspicion for pheochromocytoma.

### Why This Matters for NEET PG

**Mnemonic:** **β-cAMP-PKA = "Boost"** (increases HR, contractility, metabolism)
- cAMP is the **amplifier** of β-adrenergic signals
- Each PKA-phosphorylated target amplifies the response further
- This explains why even modest catecholamine elevation produces dramatic symptoms

Answer

A. Activation of α1-adrenergic receptors leading to increased IP3 and DAG production, causing vasoconstriction and increased cardiac contractility

Answer

C. Activation of dopamine receptors leading to increased intracellular calcium without involvement of second messengers

Answer

D. Activation of muscarinic receptors leading to decreased cAMP and reduced cardiac output

Explanation

Practice similar questions